Selected genetically engineered models relevant to human neurodegenerative disease

doi:10.1017/CBO9780511544873.016

15 - Selected genetically engineered models relevant to human neurodegenerative disease

from Part I - Basic aspects of neurodegeneration

Published online by Cambridge University Press: 04 August 2010

Anthony E. Lang and

Michael K. Lee and

M. Flint Beal: Affiliation:
Cornell University, New York
Anthony E. Lang: Affiliation:
University of Toronto
Albert C. Ludolph: Affiliation:
Universität Ulm, Germany
Donald L. Price: Affiliation:
Department of Pathology, Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
David R. Borchelt: Affiliation:
Department of Neurology, Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Michael K. Lee: Affiliation:
Department of Neurscience, Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Philip C. Wong: Affiliation:
Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Book contents

Get access

Summary

Introduction

This review on selected neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease, and frontotemporal dementia with Parkinsonism (FTD-P), focuses on the ways by which genetically engineered models have clarified the mechanisms of these disorders and have identified new targets for therapy, and been used to test new treatment strategies. These neurodegenerative diseases are some of the most challenging diseases in medicine because of their general prevalence, cost, lack of mechanism-based treatments, and impact on individuals and caregivers (Lipp & Wolfer, 1998; Wong et al., 2002). The classical clinical phenotypes are, for the most part, quite distinct and reflect the dysfunction and death of specific populations of neurons. These brain lesions are characterized by the presence of intracellular or extracellular peptides/aggregates, which appear to be critical contributors to neurotoxicity, partially damaging to synapses. Genetic risk factors influence these age-associated, chronic illnesses. In rare instances, cases are inherited in Mendelian fashion (usually as autosomal dominants). Susceptibility genes, environmental risk factors, or other influences remain to be defined. Information from genetics has allowed investigators to express or to target genes in efforts to model these diseases and to study the (Armstrong et al., 1996) molecular participants critical in pathogenic pathways. This body of research is the principal topic of this review.

In this review, we emphasize the value of genetically engineered mouse models for studies of mechanisms and for experimental therapeutics, but we also briefly describe the extraordinary utility of non-mammalian genetic models.

Type: Chapter
Information: Neurodegenerative Diseases
Neurobiology, Pathogenesis and Therapeutics
, pp. 176 - 195

DOI: https://doi.org/10.1017/CBO9780511544873.016 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Abeliovich, A., Schmitz, Y., Farinas, I.et al. (2000). Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron, 25, 239–52CrossRef Google Scholar PubMed

Armstrong, R. A., Cairns, N. J., Myers, D., Smith, C. U. M., Lantos, P. L. & Rossor, M. N. (1996). A comparison of β-amyloid deposition in the medial temporal lobe in sporadic Alzheimer's disease, Down's syndrome and normal elderly brains. Neurodegeneration, 5, 35–41CrossRef Google Scholar PubMed

Baron, M. S., Vitek, J. L., Bakay, R. A. E.et al. (1996). Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann. Neurol., 40, 355–66CrossRef Google Scholar PubMed

Benoist, C. & Mathis, D. (1997). Cell death mediators in autoimmune diabetes – no shortage of suspects. Cell, 89, 1–3CrossRef Google Scholar PubMed

Bird, T., Knopman, D., VanSwieten, J.et al. (2003). Epidemiology and genetics of frontotemporal dementia/Pick's disease. Ann. Neurol., 54 Suppl 5, S29–31CrossRef Google Scholar PubMed

Borchelt, D. R., Guarnieri, M., Wong, P. C.et al. (1995). Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J. Biol. Chem., 270, 3234–8CrossRef Google Scholar

Braak, H., Sandmann-Keil, D., Gai, W. & Braak, E. (1999). Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci. Lett., 265, 67–9CrossRef Google Scholar PubMed

Braak, H., Rub, U., Sandmann-Keil, D.et al. (2000). Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol. (Berl.), 99, 489–95CrossRef Google Scholar PubMed

Brown, A. (2000). Slow axonal transport: stop and go traffic in the axon. Nat. Rev. Molec. Cell Biol., 1, 153–6CrossRef Google Scholar PubMed

Bruijn, L. I., Becher, M. W., Lee, M. K.et al. (1997). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron, 18, 327–8CrossRef Google Scholar PubMed

Bruijn, L. I., Houseweart, M. K., Kato, S.et al. (1998). Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science, 281, 1851–4CrossRef Google Scholar PubMed

Caceres, A. & Kosik, K. J. (1990). Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature, 343, 461–3CrossRef Google Scholar PubMed

Cai, H., Wang, Y., McCarthy, D.et al. (2001). BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat. Neurosci., 4, 233–4CrossRef Google Scholar PubMed

Cao, X. & Südhof, T. C. (2001). A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science, 293, 115–20CrossRef Google Scholar PubMed

Chen, G., Chen, K. S., Knox, J.et al. (2000). A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease. Nature, 408, 975–9CrossRef Google Scholar

Chen, F., Yu, G., Arawaka, S.et al. (2001). Nicastrin binds to membrane-tethered Notch. Nat. Cell Biol., 3, 751–4CrossRef Google Scholar PubMed

Cherny, R. A., Atwood, C. S., Xilinas, M. E.et al. (2001). Treatment with a copper–zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron, 30, 665–76CrossRef Google Scholar PubMed

Chung, H. M. & Struhl, G. (2001). Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila. Nat. Cell Biol., 3, 1129–32CrossRef Google Scholar PubMed

Chung, K. K., Zhang, Y., Lim, K. L.et al. (2001). Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med., 7, 1144–50CrossRef Google Scholar PubMed

Cleveland, D. W., Hwo, S.-Y. & Kirschner, M. W. (1977a). Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J. Mol. Biol., 116, 227–47CrossRef Google Scholar

Cleveland, D. W., Hwo, S.-Y. & Kirschner, M. W. (1977b). Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J. Mol. Biol., 116, 207–25CrossRef Google Scholar

Cleveland, D. W. & Rothstein, J. D. (2001). From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci., 2, 806–19CrossRef Google Scholar PubMed

Dawson, T., Mandir, A. & Lee, M. (2002). Animal models of PD: pieces of the same puzzle?Neuron, 35, 219–22CrossRef Google Scholar PubMed

DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J. C., Paul, S. M. & Holtzman, D. M. (2001). Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA, 98, 8850–5CrossRef Google Scholar

Duff, K., Knight, H., Refolo, L. M.et al. (2000). Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiol. Dis., 7, 87–98CrossRef Google Scholar PubMed

Dumanchin, C., Camuzat, A., Campion, D.et al. (1998). Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum. Mol. Genet., 7, 1825–9CrossRef Google Scholar PubMed

Dunnett, S. B. & Bjorklund, A. (1999). Prospects for new restorative and neuroprotective treatments in Parkinson's Disease. Nature, 399, A32–9CrossRef Google Scholar PubMed

Edbauer, D., Winkler, E., Haass, C. & Steiner, H. (2002). Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. Proc. Natl Acad. Sci., USA, 99, 8666–71CrossRef Google Scholar PubMed

Feany, M. B. (2000). Studying human neurodegenerative diseases in flies and worms. J. Neuropath. Exp. Neurol., 59, 847–56CrossRef Google Scholar PubMed

Finney, L. A. & O'Halloran, T. V. (2003). Transition metal speciation in the cell: insights from the chemistry of metal ion receptors. Science, 300, 931–6CrossRef Google Scholar PubMed

Foix, M. C. (1921). Les lesions anatomiques de la maladie de Parkinson. Rev. Neurol., 28, 595–600Google Scholar

Forno, L. S. (1966). Pathology of parkinsonism. A preliminary report of 24 cases. J. Neurosurg., 24, 266–71Google Scholar

Forno, L. S., Langston, J. W., DeLanney, L. E., Irwin, I. & Ricaurte, G. A. (1986). Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann. Neurol., 20, 449–55CrossRef Google Scholar PubMed

Francis, R., McGrath, G., Zhang, J.et al. (2002). aph-1 and pen-2 are required for notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cel., 3, 85–97CrossRef Google Scholar PubMed

George, J. M., Jin, H., Woods, W. S. & Clayton, D. F. (1995). Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron, 15, 361–72CrossRef Google Scholar PubMed

Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q. & Lee, V. M. (2002). Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron, 34, 521–33CrossRef Google Scholar PubMed

Giasson, B. I., Forman, M. S., Higuchi, M.et al. (2003). Initiation and synergistic fibrillization of tau and alpha-synuclein. Science, 300, 636–40CrossRef Google Scholar PubMed

Goedert, M. (1997). The awakening of α-synuclein. Nature, 388, 232–3CrossRef Google Scholar PubMed

Goedert, M. (2001a). Alpha-synuclein and neurodegenerative diseases. Nature, 2, 492Google Scholar

Goedert, M. (2001b). The significance of tau and α-synuclein inclusions in neurodegenerative diseases. Curr. Opin. Genet. Dev., 11, 343–51CrossRef Google Scholar

Goldstein, L. S. B. & Yang, Z. (2000). Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu. Rev. Neurosci., 23, 39–71CrossRef Google Scholar PubMed

Gotz, J., Chen, F., Dorpe, J. & Nitsch, R. M. (2001). Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta fibrils. Science, 293, 1491–5CrossRef Google Scholar

Greenfield, J. G. & Bosanquet, F. D. (1953). The brain-stem lesions in parkinsonism. J. Neurol. Neurosurg. Psychiatr., 16, 213–26CrossRef Google Scholar PubMed

Harada, A., Oguchi, K., Okabe, S. et al. (1994). Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature, 369, 488–91CrossRef Google Scholar PubMed

Hassler, R. (1938). Zur Pathologie der Paralysis agitans und des postencephalitischen Parkinsonismus. J. Psychol. Neurol. (Lpz.), 48, 367–476Google Scholar

Heber, S., Herms, J., Gajic, V.et al. (2000). Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci., 20, 7951–63CrossRef Google Scholar PubMed

Higuchi, M., Ishihara, T., Zhang, B.et al. (2002). Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron, 35, 433–46CrossRef Google Scholar PubMed

Higuchi, S., Arai, H. & Matsushita, S. (1998). Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies. Exp. Neurol., 153, 164–6CrossRef Google Scholar PubMed

Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V.et al. (1998). Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science, 282, 1914–17CrossRef Google Scholar PubMed

Hu, Y., Ye, Y. & Fortini, M. E. (2002). Nicastrin is required for gamma-secretase cleavage of the Drosophila Notch receptor. Dev. Cel., 2, 69–78CrossRef Google Scholar PubMed

Hutton, M., Lendon, C. L., Rizzu, P.et al. (1998). Association of missense and 5-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393, 702–5CrossRef Google Scholar PubMed

Imai, Y., Soda, M. & Takahashi, R. (2000). Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem., 275, 35661–4CrossRef Google Scholar PubMed

Irizarry, M. C., Kim, T. W., McNamara, M.et al. (1996). Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J. Neuropathol. Exp. Neurol., 55, 889–95CrossRef Google Scholar PubMed

Ishihara,, T., Hong, M., Zhang, B.et al. (1999). Age-dependent emergence and progression of a taupathy in transgenic mice overexpressing the shortest human tau isoform. Neuron, 24, 751–62CrossRef Google Scholar

Jan, G. G., Veldink, J. H., , d. T., I.et al. (2003). A randomized sequential trial of creatine in amyotrophic lateral sclerosis. Ann. Neurol., 53, 437–45Google Scholar

Johnson, G. V. & Hartigan, J. A. (1999). Tau protein in normal and Alzheimer's disease brain: an update. J. Alzheimers Dis., 1, 329–51CrossRef Google Scholar PubMed

Julien, J.-P. (2001). Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell, 104, 581–91CrossRef Google Scholar PubMed

Kaether, C., Lammich, S., Edbauer, D.et al. (2002). Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane. J. Cell Biol., 158, 551–61CrossRef Google Scholar

Kamal, A., Almenar-Queralt, A., LeBlanc, J. F., Roberts, E. A. & Goldstein, L. S. (2001). Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature, 414, 643–8CrossRef Google Scholar PubMed

Kitada, T., Asakawa, S., Hattori, N.et al. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605–8CrossRef Google Scholar

Kopan, R. & Goate, A. (2002). Aph-2/Nicastrin: an essential component of gamma-secretase and regulator of notch signaling and presenilin localization. Neuron, 33, 321–4CrossRef Google Scholar PubMed

Kriz, J., Gowing, G. & Julien, J. P. (2003). Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann. Neuro., 53, 429–36CrossRef Google Scholar PubMed

Kruger, R., Kuhn, W., Muller, T.et al. (1998). Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet., 18, 106–8CrossRef Google Scholar PubMed

LaMonte, B. H., Wallace, K. E., Holloway, B. A.et al. (2002). Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron, 34, 715–27CrossRef Google Scholar PubMed

Laptook, A. R., Corbett, R. J. T., Arencibia-Mireles, O., Ruley, J. & Garcia, D. (1994). The effects of systemic glucose concentration on brain metabolism following repeated brain ischemia. Brain Res., 638, 78–84CrossRef Google Scholar PubMed

Lazarov, O., Lee, M., Peterson, D. A. & Sisodia, S. S. (2002). Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J. Neurosci., 22, 9785–93CrossRef Google Scholar PubMed

Lee, M. K. & Price, D. L. (2001). Advances in genetic models of Parkinson's diseases. Clin. Neurosci. Res., 1, 456–66CrossRef Google Scholar

Lee, M. K., Stirling, W. & Xu, Y. (2002). Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl Acad. Sci., USA, 99, 8968–73CrossRef Google Scholar PubMed

Lee, V. M. Y. & Trojanowski, J. Q. (1999). Neurodegenerative taupathies: human disease and transgenic mouse models. Neuron, 24, 507–10CrossRef Google Scholar

Lee, V. M., Goedert, M. & Trojanowski, J. Q. (2001). Neurodegenerative tauopathies. Annu. Rev. Neurosci., 24, 1121–59CrossRef Google Scholar PubMed

Leem, J. Y., Vijayan, S., Han, P.et al. (2002). Presenilin 1 is required for maturation and cell surface accumulation of nicstrin. J. Biol. Chem., 277, 19236–40CrossRef Google Scholar

Lewis, J., McGowan, E., Rockwood, J.et al. (2000). Neurofibrillary tangles, amyotrophy and progressive disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet., 25, 402–5CrossRef Google Scholar PubMed

Lewis, J., Dickson, D. W., Lin, W.-L.et al. (2001). Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science, 293, 1487–91CrossRef Google Scholar PubMed

Li, M., Ona, V. O., Gugan, C.et al. (2000). Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science, 288, 335–9CrossRef Google Scholar

Lim, G. P., Yang, F., Chu, T.et al. (2000). lbuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci., 20, 5709–14CrossRef Google Scholar

Lin, X., Cummings, C. J. & Zoghbi, H. Y. (1999). Expanding our understanding of polyglutamine diseases through mouse models. Neuron, 24, 499–502CrossRef Google Scholar PubMed

Lipp, H. P. & Wolfer, D. P. (1998). Genetically modified mice and cognition. Curr. Opin. Neurobiol., 8, 272–80CrossRef Google Scholar PubMed

Lopez-Schier, H. & St Johnston, D. (2002). Drosophila nicastrin is essential for the intramembranous cleavage of notch. Dev. Cel., 2, 79–89CrossRef Google Scholar PubMed

Lozano, A. M., Lang, A. E., Hutchinson, W. D. & Dostrovsky, J. O. (1998). New developments in understanding the etiology of Parkinson's Disease and in its treatments. Curr. Opin. Neurobiol., 8, 783–90CrossRef Google Scholar

Lozano, A. M., Lang, A. E., Hutchison, W. D. & Dostrovsky, J. O. (1998). New developments in understanding the etiology of Parkinson's disease and in its treatment. Curr. Opin. Neurobiol., 8, 783–90CrossRef Google Scholar PubMed

Lucking, C. B., Durr, A., Bonifati, V.et al. (2000). Association between early-onset Parkinson's disease and mutations in the parkin gene. N. Engl. J. Med., 342, 1560–7CrossRef Google Scholar PubMed

Luo, Y., Bolon, B. & Kahn, S. (2001). Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation. Nature, 4, 231–2Google Scholar PubMed

Markham, C. H. & Diamond, S. G. (1993). Clinical overview of Parkinson's disease. Clin. Neurosci., 1, 5–11Google Scholar

Maroteaux, L., Campanelli, J. T. & Scheller, R. H. (1988). Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci., 8, 2804–15CrossRef Google Scholar PubMed

Masliah, E., Rockenstein, E. & Veinbergs, I. (2000). Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science, 287, 1265–9CrossRef Google Scholar PubMed

Mercken, M., Fischer, I., Kosik, K. S. & Nixon, R. A. (1995). Three distinct axonal transport rates for tau, tubulin, and other microtubule-associated proteins: evidence for dynamic interactions of tau with microtubules in vivo. J. Neurosci., 15, 8259–67CrossRef Google Scholar PubMed

Munoz, D. G., Dickson, D. W., Bergeron, C., Mackenzie, I. R., Delacourte, A. & Zhukareva, V. (2003). The neuropathology and biochemistry of frontotemporal dementia. Ann. Neurol., 54 Suppl 5, S24–8CrossRef Google Scholar PubMed

Nicoll, J. A., Wilkinson, D., Holmes, C., Steart, P., Markham, H. & Weller, R. O. (2003). Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat. Med., 9, 448–52CrossRef Google Scholar PubMed

Olanow, C. W. & Tatton, W. G. (1999). Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci., 22, 123–44CrossRef Google Scholar PubMed

Oppenheimer, D. R. & Esiri, M. M. (1992). Diseases of the basal ganglia, cerebellum and motor neurons. In Greenfield's Neuropathology, ed. J. H. Adams & L. W. Duchen, pp. 988–1045. New York: Oxford University Press

Pasquier, F., Fukui, T., Sarazin, M.et al. (2003). Laboratory investigations and treatment in frontotemporal dementia. Ann. Neurol., 54 Suppl 5, S32–5CrossRef Google Scholar PubMed

Polymeropoulos, M. H. (1998). Autosomal dominant Parkinson's disease and alpha-synuclein. Ann. Neurol., 44, S63–4CrossRef Google Scholar PubMed

Polymeropoulos, M. H., Lavedan, C., Leroy, E.et al. (1997). Mutation in the alphasynuclein gene identified in families with Parkinson's disease. Science, 276, 2045–7CrossRef Google Scholar

Price, D. L., Tanzi, R. E., Borchelt, D. R. & Sisodia, S. S. (1998). Alzheimer's disease: genetic studies and transgenic models. Annu. Rev. Genet., 32, 461–93CrossRef Google Scholar PubMed

Probst, A., Götz, J., Wiederhold, K. H.et al. (2000). Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol., 99, 469–81CrossRef Google Scholar PubMed

Puls, I., Jonnakuty, C., LaMonte, B. H.et al. (2003). Mutant dynactin in motor neuron disease. Nat. Genet., 33, 455–6CrossRef Google Scholar PubMed

Rothstein, J. D. (2003). Of mice and men: reconciling preclinical ALS mouse studies and human clinical trials. Ann. Neurol., 53, 423–6CrossRef Google Scholar PubMed

Schenk, D., Barbour, R., Dunn, W.et al. (1999). Immunization with amyloid-beta attenuates Alzheimer disease-like pathology in the PDAPP mouse. Nature, 400, 173–7CrossRef Google Scholar PubMed

Selkoe, D. J. (2001a). Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev., 81, 741–66CrossRef Google Scholar

Selkoe, D. J. (2001b). Clearing the brain's amyloid cobwebs. Neuron, 32, 177–80CrossRef Google Scholar

Sheng, J. G., Price, D. L. & Koliatsos, V. E. (2002). Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis. J. Neurosci., 22, 9794–9CrossRef Google Scholar

Sherman, M. Y. & Goldberg, A. L. (2001). Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron, 29, 15–32CrossRef Google Scholar PubMed

Sherrington, R., Rogaev, E. I., Liang, Y.et al. (1995). Cloning of gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 375, 754–60CrossRef Google Scholar PubMed

Sima, A. A. F., Defendini, R., Keohane, C.et al. (1996). The neuropathology of chromosome 17-linked dementia. Ann. Neurol., 39, 734–43CrossRef Google Scholar PubMed

Sisodia, S. S. & George-Hyslop, P. H. (2002). gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?Nat. Rev. Neurosci., 3, 281–90CrossRef Google Scholar PubMed

Spillantini, M. G., Schmidt, V. M. L., Trojanowski, J. Q., Jakes, R. & Goedert, M. (1997). Alpha-synuclein in lewy bodies [letter]. 839–40

Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A. & Ghetti, B. (1998). Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci., USA, 95, 7737–41CrossRef Google Scholar PubMed

Spittaels, K., Haute, C., Dorpe, J.et al. (1999). Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol., 155, 2153–65CrossRef Google Scholar PubMed

Subramaniam, J. R., Lyons, W. E. & Liu, J. (2002). Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci., 5, 301–7CrossRef Google Scholar PubMed

Südhof, T. C. (1995). The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature, 375, 645–53CrossRef Google Scholar PubMed

Takei, Y., Kondo, S., Harada, A., Inomata, S., Noda, T. & Hirokawa, N. (1997). Delayed development of nervous system in mice homozygous for disrupted microtubule-associated protein 1B (MAP1B) gene. J. Cell Biol., 137, 1615–26CrossRef Google Scholar PubMed

Takei, Y., Teng, J., Harada, A. & Hirokawa, N. (2000). Defects in axonal elongation and neuronal migration in mice with disrupted tau and map 1b genes. J. Cell Biol., 150, 989–1000CrossRef Google Scholar

Taniguchi, Y., Karlstrom, H., Lundkvist, J.et al. (2002). Notch receptor cleavage depends on but is not directly executed by presenilins. Proc. Natl Acad. Sci., USA, 99, 4014–19CrossRef Google Scholar

Tanzi, R. E. & Bertram, L. (2001). New frontiers in Alzheimer's disease genetics. Neuron, 32, 181–4CrossRef Google Scholar PubMed

Terada, S. & Hirokawa, K. (2000). Moving on to the cargo problem of microtubule-dependent motors in neurons. Curr. Opin. Neurobiol., 10, 566–73CrossRef Google Scholar PubMed

Trojanowski, J. Q. (2002). Tauists, baptists, syners, apostates, and new data. Ann. Neurol., 52, 263–5CrossRef Google Scholar PubMed

Ueda, K., Fukushima, H., Masliah, E.et al. (1993). Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl Acad. Sci. USA, 90, 11282–6CrossRef Google Scholar PubMed

Putten, H., Wiederhold, K. H., Probst, A., et al. (2000). Neuropathology in mice expressing human alpha-synuclein. J. Neurosci., 20, 6021–9CrossRef Google Scholar PubMed

Vassar, R., Bennett, B. D., Babu-Khan, S.et al. (1999). β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 286, 735–41CrossRef Google Scholar PubMed

Vassar, R. & Citron, M. (2000). Aβ-generating enzymes: recent advances in β- and γ-secretase research. Neuron, 27, 419–22CrossRef Google Scholar PubMed

Vázques, J., Fernández-Shaw, C., Marina, A., Haas, C., Cacabelos, R. & Valdivieso, F. (1996). Antibodies to human brain spectrin in Alzheimer's disease. J. Neuroimmunol., 68, 39–44Google Scholar

Wang, J., Xu, G. & Borchelt, D. R. (2002). High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation. Neurobiol. Dis., 9, 139–48CrossRef Google Scholar PubMed

Warrick, J. M., Paulson, H. L., Gray-Board, Y. E.et al. (1998). Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell, 93, 939–49CrossRef Google Scholar PubMed

Warrick, J. M., Chan, H., Gray-Board, Y. E., Chai, Y., Paulson, H. L. & Bonini, N. M. (1999). Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet., 23, 425–8CrossRef Google Scholar PubMed

Weggen, S., Eriksen, J. L., Das, P.et al. (2001). A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature, 414, 212–16CrossRef Google Scholar PubMed

Wichmann, T. & DeLong, M. R. (1996). Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol., 6, 752–8CrossRef Google Scholar PubMed

Wittmann, C. W., Wszolek, M. F., Shulman, J. M.et al. (2001). Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science, 293, 711–14CrossRef Google Scholar PubMed

Wong, P. C., Pardo, C. A., Borchelt, D. R.et al. (1995). An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 14, 1105–16CrossRef Google Scholar PubMed

Wong, P. C., Zheng, H., Chen, H.et al. (1997). Presenilin 1 is required for Notch 1 and DII1 expression in the paraxial mesoderm. Nature, 387, 288–92CrossRef Google Scholar PubMed

Wong, P. C., Rothstein, J. D. & Price, D. L. (1998). The genetic and molecular mechanisms of motor neuron disease. Curr. Opin. Neurobiol., 8, 791–9CrossRef Google Scholar PubMed

Wong, P. C., Waggoner, D., Subramaniam, J. R.et al. (2000). Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc. Natl Acad. Sci., USA, 97, 2886–91CrossRef Google Scholar PubMed

Wong, P. C., Price, D. L. & Cai, H. (2001). The brain's susceptibility to amyloid plaques. Science, 293, 1434–5CrossRef Google Scholar PubMed

Wong, P. C., Cai, H., Borchelt, D. R. & Price, D. L. (2002). Genetically engineered mouse models of neurodegenerative diseases. Nat. Neurosci., 5, 633–9CrossRef Google Scholar PubMed

Yu, G., Nishimura, M., Arawaka, S.et al. (2000). Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature, 407, 48–54Google Scholar PubMed

Zhang, Y., Gao, J., Chung, K. K.et al. (2000). Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptuc vesicle-associated protein, CDCrel-1. Proc. Natl Acad. Sci., USA, 97, 13354–9CrossRef Google Scholar PubMed

Zheng, H., Jiang, M.-H., Trumbauer, M. E.et al. (1995). β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell, 81, 525–31CrossRef Google Scholar PubMed

Zhu, S., Stavrovskaya, I. G., Drozda, M.et al. (2002). Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature, 417, 74–8CrossRef Google Scholar PubMed